# PRAX (Praxis Precision Medicines, Inc.) - SEC EDGAR Financial Statements

> Praxis Precision Medicines, Inc. reported $0 in revenue and a net loss of $359.4M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/PRAX
- Markdown: https://convexityos.com/fundamentals/PRAX.md
- SEC CIK: 0001689548
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001689548&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$406.7M | Operating profit |
| Net Income | FY 2025 | -$359.4M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$12.32 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$323.6M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $745.3M | Total debt: $732K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $8.55M | $2.45M | $0 | -- | -- | -- |
| Research & Development | $267.1M | $152.4M | $86.77M | $155.0M | $120.3M | $44.98M | $29.56M |
| Total Operating Expenses | $326.2M | $208.7M | $128.8M | $215.0M | $167.3M | $61.97M | $35.79M |
| **Operating Income** | -$326.2M | -$200.2M | -$126.4M | -$215.0M | -$167.3M | -$61.97M | -$35.79M |
| **EBITDA** | -$326.1M | -$199.8M | -$125.9M | -$214.6M | -$167.2M | -$61.92M | -$35.75M |
| Interest Income | -- | -- | -- | $957K | $271K | $140K | $193K |
| Income Before Tax | -$302.8M | -$182.7M | -$123.0M | -- | -$167.1M | -$61.83M | -$35.60M |
| Income Tax Expense | $471K | -- | -- | -- | $0 | -$8.0K | -$84K |
| **Net Income** | -$303.3M | -$182.8M | -$123.3M | -$214.0M | -$167.1M | -$61.82M | -$35.51M |
| Basic EPS | -$13.48 | -$10.21 | -$18.69 | -$69.65 | -$59.10 | -$117.90 | -$399.00 |
| **Diluted EPS** | -$13.48 | -$10.21 | -$18.69 | -$69.65 | -$59.10 | -$117.90 | -$399.00 |
| Basic Shares Outstanding | 22.5M | 17.9M | 6.6M | 3.1M | 2.8M | 596.7K | 102.0K |
| Diluted Shares Outstanding | 22.5M | 17.9M | 6.6M | 3.1M | 2.8M | 596.7K | 102.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $0 | $0 | $7.46M |
| Research & Development | $64.20M | $69.42M | $77.99M | $77.51M | $65.80M | $63.01M | $60.81M | $56.29M |
| Total Operating Expenses | $106.9M | $96.90M | $105.9M | $97.04M | $78.36M | $76.07M | $74.73M | $71.42M |
| **Operating Income** | -$106.9M | -$96.90M | -$105.9M | -$97.04M | -$78.36M | -$76.07M | -$74.73M | -$63.96M |
| **EBITDA** | -$106.9M | -$96.87M | -$105.8M | -$97.02M | -$78.34M | -$76.02M | -$74.68M | -$63.91M |
| **Net Income** | -$94.23M | -$83.72M | -$92.56M | -$88.91M | -$73.93M | -$71.13M | -$69.30M | -$58.68M |
| Basic EPS | -$3.23 | -$2.87 | -$3.20 | -- | -$3.36 | -$3.31 | -$3.29 | -- |
| **Diluted EPS** | -$3.23 | -$2.87 | -$3.20 | -- | -$3.36 | -$3.31 | -$3.29 | -- |
| Basic Shares Outstanding | 29.2M | 29.1M | 28.9M | -- | 22.0M | 21.5M | 21.1M | -- |
| Diluted Shares Outstanding | 29.2M | 29.1M | 28.9M | -- | 22.0M | 21.5M | 21.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $357.3M | $215.4M | $81.30M | $61.62M | $138.7M | $296.6M | $44.81M |
| Short-Term Investments | $242.0M | $177.2M | $0 | $38.87M | $105.7M | -- | -- |
| **Cash & Short-Term Investments** | $926.1M | $469.5M | $0 | $100.5M | $275.9M | $296.6M | $44.81M |
| **Total Current Assets** | $610.9M | $404.4M | $84.88M | $110.8M | $287.4M | $302.3M | $45.50M |
| Property, Plant & Equipment, Net | $147K | $230K | $588K | $971K | $1.21M | $82K | $128K |
| Intangible Assets | $0 | -- | -- | -- | -- | -- | -- |
| Long-Term Investments | $326.8M | $76.96M | $0 | -- | $31.53M | -- | -- |
| Other Non-Current Assets | $0 | $416K | $416K | $416K | $472K | $15K | $620K |
| **Total Non-Current Assets** | $327.0M | $78.74M | $3.07M | $4.29M | $5.34M | $851K | $2.20M |
| **Total Assets** | $937.9M | $483.1M | $87.95M | $115.1M | $292.7M | $303.2M | $47.69M |
| Accounts Payable | $24.63M | $12.53M | $5.82M | $14.67M | $10.78M | $4.09M | $2.67M |
| Deferred Revenue (Current) | -- | $0 | $1.39M | $2.82M | $0 | -- | -- |
| **Total Current Liabilities** | $59.77M | $37.55M | $15.75M | $34.34M | $38.43M | $15.72M | $6.82M |
| Deferred Revenue (Non-Current) | -- | $0 | $1.16M | $2.18M | $0 | -- | -- |
| **Total Non-Current Liabilities** | $0 | $110K | $2.53M | $4.68M | $3.50M | $0 | $763K |
| **Total Liabilities** | $59.77M | $37.66M | $18.28M | $39.02M | $41.94M | $15.72M | $7.58M |
| **Total Debt (incl. Leases)** | $110K | $1.37M | $2.50M | $3.50M | $4.31M | $763K | $1.46M |
| Common Stock | $15K | $14K | $13K | $5.0K | $5.0K | $4.0K | $1.0K |
| Retained Earnings | -$1.14B | -$836.7M | -$653.9M | -$530.6M | -$316.6M | -$149.6M | -$81.01M |
| Accumulated Other Comp. Income | $563K | $654K | $0 | -$173K | -$176K | $0 | -- |
| **Total Stockholders' Equity** | $878.1M | $445.4M | $69.67M | $76.11M | $250.8M | $287.5M | -$81.01M |
| Total Equity | $878.1M | $445.4M | $69.67M | $76.11M | $250.8M | $287.5M | -$81.01M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $361.9M | $474.8M | $536.3M | $357.3M | $149.5M | $157.4M | $165.6M | $215.4M |
| Short-Term Investments | $383.5M | $283.8M | $250.5M | $242.0M | $117.6M | $143.9M | $162.4M | $177.2M |
| **Cash & Short-Term Investments** | $1.30B | $1.40B | $1.40B | $926.1M | $389.2M | $446.6M | $472.0M | $469.5M |
| **Total Current Assets** | $762.8M | $771.9M | $797.8M | $610.9M | $273.8M | $306.6M | $333.6M | $404.4M |
| Property, Plant & Equipment, Net | $1.90M | $492K | $170K | $147K | $174K | $258K | $247K | $230K |
| Intangible Assets | -- | $773K | -- | $0 | -- | -- | -- | -- |
| Long-Term Investments | $540.7M | $615.3M | $660.9M | $326.8M | $122.0M | $145.4M | $144.0M | $76.96M |
| Other Non-Current Assets | $6.00M | $643K | -- | $0 | $0 | $0 | $0 | $416K |
| **Total Non-Current Assets** | $549.3M | $618.2M | $662.4M | $327.0M | $122.5M | $146.3M | $145.2M | $78.74M |
| **Total Assets** | $1.31B | $1.39B | $1.46B | $937.9M | $396.4M | $452.8M | $478.7M | $483.1M |
| Accounts Payable | $15.02M | $23.39M | $31.16M | $24.63M | $30.82M | $28.83M | $22.91M | $12.53M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $52.50M | $49.06M | $50.24M | $59.77M | $52.88M | $48.61M | $39.52M | $37.55M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $110K |
| **Total Liabilities** | $52.50M | $49.06M | $50.24M | $59.77M | $52.88M | $48.61M | $39.52M | $37.66M |
| **Total Debt (incl. Leases)** | $732K | $1.09M | $1.44M | $110K | $436K | $755K | $1.07M | $1.37M |
| Common Stock | $15K | $15K | $15K | $15K | $14K | $14K | $14K | $14K |
| Retained Earnings | -$1.41B | -$1.32B | -$1.23B | -$1.14B | -$1.05B | -$977.2M | -$906.0M | -$836.7M |
| Accumulated Other Comp. Income | -$5.73M | -$2.67M | -$1.59M | $563K | $500K | $395K | $659K | $654K |
| **Total Stockholders' Equity** | $1.26B | $1.34B | $1.41B | $878.1M | $343.5M | $404.2M | $439.2M | $445.4M |
| Total Equity | $1.26B | $1.34B | $1.41B | $878.1M | $343.5M | $404.2M | $439.2M | $445.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$303.3M | -$182.8M | -$123.3M | -$214.0M | -$167.1M | -$61.82M | -$35.51M |
| Depreciation & Amortization | $140K | $358K | $432K | $419K | $182K | $50K | $37K |
| Stock-Based Compensation | $33.94M | $41.36M | $24.86M | $28.59M | $22.69M | $5.21M | $668K |
| Change in Payables | $12.10M | $6.71M | -$8.86M | $3.89M | $7.27M | $960K | -$837K |
| **Operating Cash Flow** | -$249.1M | -$131.8M | -$111.1M | -$185.0M | -$124.6M | -$52.62M | -$33.42M |
| Capital Expenditure | -$56K | $0 | -$50K | -$444K | -$1.05M | $0 | -$103K |
| **Free Cash Flow** | -$249.1M | -$131.8M | -$111.2M | -$185.5M | -$125.6M | -$52.62M | -$33.52M |
| Purchases of Investments | -$623.8M | -$371.5M | $0 | -$83.02M | -$164.2M | $0 | -- |
| **Investing Cash Flow** | -$311.1M | -$248.5M | $38.95M | $96.89M | -$140.5M | $0 | -$103K |
| Common Stock Issued | $1.80B | $1.10B | $617.5M | $0 | $98.41M | $0 | -- |
| **Financing Cash Flow** | $702.2M | $514.3M | $91.87M | $10.46M | $107.6M | $304.4M | $60.39M |
| **Net Change in Cash** | $142.0M | $134.1M | $19.68M | -$77.69M | -$157.5M | $251.8M | $26.86M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$94.23M | -$83.72M | -$92.56M | -$88.91M | -$73.93M | -$71.13M | -$69.30M | -$58.68M |
| Depreciation & Amortization | $33K | $33K | $39K | $28K | $19K | $46K | $47K | $47K |
| Stock-Based Compensation | $14.89M | $11.31M | $17.11M | $9.94M | $7.45M | $7.77M | $8.79M | $8.57M |
| Change in Payables | -$8.26M | -$7.88M | $6.53M | -$6.19M | $1.99M | $5.92M | $10.38M | -$2.48M |
| **Operating Cash Flow** | -$81.74M | -$77.54M | -$86.15M | -$76.33M | -$65.06M | -$54.68M | -$53.01M | -$56.12M |
| Capital Expenditure | -$1.55M | -$245K | -$62K | $0 | $0 | -$56K | $0 | -- |
| **Free Cash Flow** | -$83.29M | -$77.79M | -$86.21M | -$76.33M | -$65.06M | -$54.73M | -$53.01M | -- |
| Purchases of Investments | -$156.7M | -$77.27M | -$486.8M | -$390.3M | -$75.13M | -$41.35M | -$117.1M | -$69.42M |
| **Investing Cash Flow** | -$32.10M | $10.98M | -$344.3M | -$328.4M | $50.41M | $17.89M | -$51.06M | -$10.92M |
| Common Stock Issued | $0 | $0 | $2.40B | $600.0M | $0 | $0 | $1.20B | $100.0M |
| **Financing Cash Flow** | $929K | $4.57M | $609.4M | $612.5M | $6.76M | $28.63M | $54.27M | $113.8M |
| **Net Change in Cash** | -$112.9M | -$61.99M | $179.0M | $207.8M | -$7.89M | -$8.15M | -$49.80M | $46.73M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -2340.3% | -5164.4% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -2137.5% | -5037.9% | -- | -- | -- | -- |
| Return on Equity (ROE) | -34.5% | -41.0% | -176.9% | -281.2% | -66.6% | -21.5% | -- |
| Return on Assets (ROA) | -32.3% | -37.8% | -140.2% | -185.9% | -57.1% | -20.4% | -74.5% |
| Current Ratio | 10.22x | 10.77x | 5.39x | 3.23x | 7.48x | 19.23x | 6.67x |
| Quick Ratio | 15.49x | 12.50x | 0.00x | 2.93x | 7.18x | 18.87x | 6.57x |
| Debt to Equity | 0.00x | 0.00x | 0.04x | 0.05x | 0.02x | 0.00x | -- |
| **Revenue Growth (YoY)** | -100.0% | +249.5% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -3927.5% | -3497.6% | -2868.8% | -2340.3% |
| **Net Profit Margin** | -- | -- | -- | -- | -3658.5% | -3232.6% | -2617.1% | -2137.5% |
| Return on Equity (ROE) | -28.5% | -25.3% | -23.2% | -34.5% | -79.5% | -62.1% | -48.4% | -41.0% |
| Return on Assets (ROA) | -27.4% | -24.4% | -22.4% | -32.3% | -68.9% | -55.4% | -44.4% | -37.8% |
| Current Ratio | 14.53x | 15.73x | 15.88x | 10.22x | 5.18x | 6.31x | 8.44x | 10.77x |
| Quick Ratio | 24.76x | 28.54x | 27.87x | 15.49x | 7.36x | 9.19x | 11.94x | 12.50x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -100.0% | -100.0% | -100.0% | +1349.1% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
